Friday, September 12, 2014

FDA approves new weight-loss pill

The drug’s California-based maker Orexigen Therapeutics said in a conference call Thursday that “the exact neurochemical effects of Contrave leading to weight loss are not fully understood.” It said the pill is believed to affect both the hypothalamus





via Get Fit Bookmark http://ift.tt/1syeRkb




via Tumblr http://ift.tt/1syffiF

No comments:

Post a Comment